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According to official statistics, Iran stands among the 
10 leading countries in terms of infection rate with over 
93 657 affected cases based on positive PCR test and 5957 
deaths caused by COVID-19 up to April 30, 2020 based 
on information available at https://www.worldometers.
info/coronavirus/.1
According to the Charter of Human Rights (Secondary 
Rights)2 and International Health Regulations (2005),3 
given the pandemic nature of COVID-19, announced by 
the World Health Organization (WHO) on March 11, 
2020,4 there is a need for cooperation of all countries to 
control this pandemic.
According to WHO regulations and the Charter of 
Human Rights, this question is raised, “is it possible for 
a country which is under the hardest possible economic 
sanctions to provide scientific recommendations to control 
COVID-19 in the short and medium-term?”
We know that control of COVID-19 focuses more on 
preventive measures such as reducing traffic, staying home, 
physical distancing, and quarantine, as no vaccine and the 
effective drug has yet been discovered for it.
Also, performing more and more diagnostic tests and 
treating more severe cases in the hospital with respiratory 
support are among the WHO recommendations.
Given what was stated above, the control and treatment 
of COVID-19 disease impose both direct and indirect 
socioeconomic costs that require government support 
packages. These costs include: 
• Direct costs; including diagnosis, screening, 
hospitalization, and treatment,
• Indirect prevention costs; including providing 
essential supplies and health items for the elderly and 
those in quarantined cities, 
• The economic costs imposed as a result of the closure 
of businesses, especially in the tourism sectors, hotels, 
transport, retail, etc, 
• The socio-economic costs caused due to closure of 
educational places, social consequences of staying 
home, isolation, quarantine, and the psychological 
consequences caused by them. Taking preventive 
measures, treatment, and reducing socioeconomic 
consequences caused by COVID-19 epidemic require 
funding for direct medical costs and supportive 
packages to reduce indirect adverse effects, which 
require government funding.
Therefore, the economic sanctions would act as 
a large barrier against effective preventive scientific 
recommendations for the control of the COVID-19 
pandemic.
Does the Control of the COVID-19 Pandemic in Iran 
Need Only Drugs, and Diagnostic and Therapeutic 
Medical Equipment? 
This pandemic requires physical distancing and closure 
of many economic activities, and meanwhile, the Iranian 
government must help people economically and provide 
food and health items to encourage them to stay home and 
maintain physical distance. Also, during this period, due to 
the closure of businesses, sources of government revenue, 
including taxation, government services, and domestic 
sales of energy and electricity have decreased dramatically, 
while production and current costs of the public sector 
and private businesses continue. Besides, the direct costs of 
preventing, screening, controlling, and treating the disease 
are under the responsibility of the government.
Hence, the continued sanctions create several problems 
for providing necessary financial sources and transferring 
them to meet these requirements and accelerate the 
purchase and import of medical and diagnostic medical 
items, which ultimately make it difficult to control this 
disease in Iran. 
If We Assume That Iran Is not Under Sanctions with 
Drugs and Medical Equipment, does it Mean That 
There Is no Problem in Supplying Drugs and Medical 
Equipment to Control COVID-19 and Other Diseases? 
Financial resources are needed for every purchase, including 
drugs and medical equipment. Thus, economic sanctions 
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depend on the money from exporting oil, petrochemical 
products, and petroleum, will cause serious problems in 
purchasing drugs and medical equipment. This problem is 
bilateral, as the export of oil and its sub-products has been 
reduced due to sanctions and the price of oil has fallen 
below $20 a barrel as a result of shocks and the sharp 
decline in demand due to the COVID-19 pandemic.5
 As a result, Iran’s foreign exchange earnings have declined 
exponentially.
Is Epidemic Control Necessary in Iran to Control the 
Global Pandemic? 
The answer is yes. All of us are living in a global village and 
all countries must do their best to control the epidemic in 
Iran and control its global pandemic.
Are Money and Resources Needed to Control the 
Epidemic in Iran? 
The answer is yes. All countries have allocated high 
budgets to the private sector, staff, and people during 
quarantine and physical distancing. Also, resource 
sufficiency is a major issue for the Iranian government 
due to continued sanctions, a sharp drop in oil prices, and 
the impossibility of exporting petrochemical products. 
Sanctions have directly targeted human rights goals. For 
example, the United States has allocated $2000 billion for 
compensating the losses caused by COVID-9.6
The German government has considered a €156 billion 
package to cope with the consequences of coronavirus.7
In coclusion it seems that COVID-19 makes our lives 
more dependent on each other than ever before, as this 
disease has spread to all countries in the shortest possible 
time. Therefore, all countries must cooperate to control 
this disease. Funding during this period is a major 
necessity for implementing physical distancing, staying at 
home, quarantine policies, providing drugs, and medical 
diagnostic equipment. 
Continuous economic sanctions are a major barrier 
for the necessary funding to take preventive and control 
measures, such as continuing physical distancing 
with the closure of businesses, reducing traffic and 
providing essential health care to the elderly people, and 
implementing the quarantine policy. 
Given the importance of epidemic control in all countries 
to succeed in controlling the global pandemic, there is a 
need to remove the economic sanctions for funding the 
implementation of direct control, prevention, treatment, 
and indirect measures such as the provision of supportive 
packages to continue physical distancing policies in Iran. 
In this critical period, any reduction in Iran’s sources of 
income as a result of sanctions will directly affect people’s 
lives and health, which is contrary to the Charter of 
Human Rights.
Hence, it is Recommended: 
• Removing the economic sanctions as the human 
impact of the sanctions is manifested in the 
COVID-19 epidemic,
• To establish special credit lines for the purchase of 
drugs and medical equipment required to control 
COVID-19 through international funds,
• Releasing the blocked Iranian money by foreign 
banks,
• Support of European and American countries for 
Iran to receive financial assistance and loans from 
international funds to cope with the adverse impact 
of the COVID-19 epidemic.
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